Company Profile

Smart Quotes

NECTAR LIFESCIENCES LTD.

NSE : NECLIFEBSE : 532649ISIN CODE : INE023H01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE22.220.12 (+0.54 %)

PREV CLOSE ( ) 22.10

OPEN PRICE ( ) 22.35

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 78143

TODAY'S LOW / HIGH ( )22.15 23.01

52 WK LOW / HIGH ( )20.05 56.39

NSE22.190.06 (+0.27 %)

PREV CLOSE( ) 22.13

OPEN PRICE ( ) 22.42

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 779704

TODAY'S LOW / HIGH( ) 22.00 22.80

52 WK LOW / HIGH ( )20.02 56.5

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 27-06 1995

Management Info

Sanjiv Goyal - Chairman Sanjiv Goyal - Managing Director

Registered Office

Address Village Saidpura,Tehsil Dera Bassi,District Sahibzada Ajit Singh Nagar,
Mohali Dist,
Punjab-140507

Phone 01762-534001 / 534002

Email sales@neclife.com

Website www.neclife.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, Luxembourg

NEWS

27Jun Nectar Lifesciences informs about clo
With reference to the Company’s earlier communication No. NLL/CS/2025/-4..

11Jun Nectar Lifesciences informs about disc
With reference to point no. 2 of Annexure 1 of letter nos. NLL/CS/2024-4..

05Apr Nectar Lifesciences informs about cert
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (..

04Apr Nectar Lifescience informs about discl
With reference to point no. 2 of Annexure 1 of letter no. NLL/CS/2024-43..

11Mar Nectar Lifesciences receives 7 observa
European Directorate for the Quality of Medicines & HealthCare (EDQM..

Financials

in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	78.4	50.01
Gross Profit	125.47	182.75
Operating Profit	452.83	1661.35
Net Sales	4549.82	16856.32

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi Cons. Health (BSE) 5695.25 (13.54%)	M.Cap ( in Cr)13116.51
Sanofi India (BSE) 6375.85 (3.03%)	M.Cap ( in Cr)14683.98
RPG Life Sciences (BSE) 2480.45 (3.18%)	M.Cap ( in Cr)4112.26
Alembic Pharma (BSE) 1042.60 (7.28%)	M.Cap ( in Cr)20493.67
Jenburkt Pharma (BSE) 1372.10 (4.95%)	M.Cap ( in Cr)605.55

Shareholding Pattern

	NON-INSTITUTION	53.67%
	PROMOTERS	44.53%
	GOVERNMENT	0.02%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found